Barbara Ann Cockrill, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 11 | 2022 | 1534 | 1.190 |
Why?
|
| Dyspnea | 4 | 2021 | 1303 | 0.620 |
Why?
|
| Education, Distance | 1 | 2021 | 251 | 0.590 |
Why?
|
| Calcium Carbonate | 1 | 2017 | 67 | 0.580 |
Why?
|
| Schools, Medical | 2 | 2021 | 881 | 0.570 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2022 | 1008 | 0.540 |
Why?
|
| Videotape Recording | 1 | 2017 | 352 | 0.520 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 581 | 0.480 |
Why?
|
| Education, Medical | 2 | 2023 | 1722 | 0.430 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2013 | 101 | 0.410 |
Why?
|
| Curriculum | 3 | 2023 | 3605 | 0.400 |
Why?
|
| Nitric Oxide | 6 | 2022 | 2132 | 0.390 |
Why?
|
| Students, Medical | 1 | 2022 | 1862 | 0.340 |
Why?
|
| Pulmonary Wedge Pressure | 3 | 2020 | 264 | 0.220 |
Why?
|
| Endothelins | 1 | 2022 | 138 | 0.210 |
Why?
|
| Heart Failure | 5 | 2022 | 10895 | 0.200 |
Why?
|
| Nitroprusside | 2 | 2001 | 275 | 0.200 |
Why?
|
| Problem-Based Learning | 2 | 2023 | 361 | 0.190 |
Why?
|
| Nifedipine | 1 | 2001 | 227 | 0.190 |
Why?
|
| Tachycardia, Sinus | 1 | 2020 | 42 | 0.180 |
Why?
|
| Exercise Tolerance | 2 | 2017 | 768 | 0.180 |
Why?
|
| Ventricular Function, Right | 2 | 2001 | 591 | 0.170 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 1999 | 14 | 0.170 |
Why?
|
| Fatal Outcome | 2 | 2020 | 1851 | 0.160 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2021 | 478 | 0.160 |
Why?
|
| Thinking | 1 | 2020 | 318 | 0.150 |
Why?
|
| Cough | 1 | 2020 | 555 | 0.140 |
Why?
|
| Pseudomonas pseudoalcaligenes | 1 | 2015 | 2 | 0.140 |
Why?
|
| Metallurgy | 1 | 2015 | 94 | 0.130 |
Why?
|
| Myocardial Contraction | 1 | 2001 | 1579 | 0.130 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2015 | 61 | 0.130 |
Why?
|
| Stroke Volume | 3 | 2020 | 5006 | 0.120 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2013 | 30 | 0.110 |
Why?
|
| Hemodynamics | 3 | 2001 | 4196 | 0.110 |
Why?
|
| Lung | 3 | 2020 | 9857 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1531 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 2047 | 0.110 |
Why?
|
| Learning | 2 | 2023 | 1711 | 0.100 |
Why?
|
| Pandemics | 2 | 2022 | 8385 | 0.100 |
Why?
|
| Echocardiography | 2 | 2020 | 5099 | 0.090 |
Why?
|
| Exercise Test | 2 | 2017 | 2073 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 345 | 0.090 |
Why?
|
| Administration, Inhalation | 4 | 2001 | 1105 | 0.080 |
Why?
|
| Weight Loss | 1 | 2020 | 2625 | 0.080 |
Why?
|
| Massachusetts | 1 | 2021 | 8662 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 1790 | 0.080 |
Why?
|
| Dopamine | 1 | 1994 | 1591 | 0.070 |
Why?
|
| Humans | 25 | 2023 | 744366 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1469 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2020 | 6442 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 1084 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2015 | 1793 | 0.060 |
Why?
|
| Palliative Care | 1 | 2020 | 3493 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 1912 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2009 | 743 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 834 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 1995 | 768 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6364 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2022 | 25628 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1873 | 0.050 |
Why?
|
| Administration, Sublingual | 1 | 2001 | 56 | 0.050 |
Why?
|
| Kidney | 1 | 1994 | 7184 | 0.040 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 132 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2001 | 2274 | 0.040 |
Why?
|
| Bronchiectasis | 1 | 1999 | 128 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 1999 | 150 | 0.040 |
Why?
|
| Aged | 8 | 2020 | 163288 | 0.040 |
Why?
|
| Mucus | 1 | 1999 | 321 | 0.040 |
Why?
|
| Vasodilation | 1 | 2001 | 944 | 0.040 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1996 | 77 | 0.030 |
Why?
|
| Adult | 10 | 2022 | 214052 | 0.030 |
Why?
|
| Bronchial Spasm | 1 | 1996 | 73 | 0.030 |
Why?
|
| Methacholine Chloride | 1 | 1996 | 233 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13104 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1995 | 216 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 1999 | 696 | 0.030 |
Why?
|
| Pulmonary Fibrosis | 1 | 1999 | 530 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Female | 13 | 2021 | 380193 | 0.030 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 1210 | 0.030 |
Why?
|
| Disinfection | 1 | 2015 | 191 | 0.030 |
Why?
|
| Teaching | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 1999 | 1463 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1181 | 0.030 |
Why?
|
| Ergonovine | 1 | 1991 | 15 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2013 | 382 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1999 | 3914 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1999 | 1178 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 1991 | 255 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 23404 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 987 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2108 | 0.020 |
Why?
|
| Workplace | 1 | 2015 | 836 | 0.020 |
Why?
|
| Heart-Lung Transplantation | 1 | 2009 | 71 | 0.020 |
Why?
|
| Water | 1 | 2015 | 1395 | 0.020 |
Why?
|
| Asthma | 2 | 1999 | 6010 | 0.020 |
Why?
|
| Middle Aged | 10 | 2017 | 213390 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2009 | 209 | 0.020 |
Why?
|
| Recurrence | 1 | 1999 | 8340 | 0.020 |
Why?
|
| Ethanolamines | 1 | 1987 | 158 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1991 | 544 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6770 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2009 | 692 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1997 | 3070 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12961 | 0.020 |
Why?
|
| Male | 10 | 2017 | 350115 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 1476 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1265 | 0.010 |
Why?
|
| Disease Progression | 1 | 1999 | 13286 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39052 | 0.010 |
Why?
|
| Critical Illness | 1 | 1994 | 2670 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 168768 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 19905 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2009 | 4576 | 0.010 |
Why?
|
| Stents | 1 | 2009 | 3282 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 1995 | 28 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1996 | 227 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1996 | 399 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1995 | 203 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2009 | 3537 | 0.010 |
Why?
|
| Spirometry | 1 | 1996 | 865 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 1996 | 502 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1991 | 41 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1994 | 739 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1994 | 936 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1994 | 597 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1996 | 1617 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15535 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1745 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1994 | 1588 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1991 | 11718 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1994 | 976 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 77460 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 85779 | 0.000 |
Why?
|
| Heparin | 1 | 1995 | 1637 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2009 | 23336 | 0.000 |
Why?
|
| Lactates | 1 | 1987 | 432 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20130 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1987 | 402 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1994 | 6459 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 63107 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1994 | 2400 | 0.000 |
Why?
|
| Heart Transplantation | 1 | 1994 | 3112 | 0.000 |
Why?
|
| Fasting | 1 | 1987 | 1592 | 0.000 |
Why?
|
| Survival Rate | 1 | 1994 | 12788 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1994 | 9145 | 0.000 |
Why?
|
| Proteins | 1 | 1994 | 6100 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1987 | 1826 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1994 | 8551 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1987 | 6254 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 57776 | 0.000 |
Why?
|
| Pregnancy | 1 | 1991 | 29144 | 0.000 |
Why?
|